Table 1.
Women | Children |
Postpartum haemorrhage | Pneumonia |
Oxytocin | Amoxicillin |
Misoprostol | Ampicillin |
Sodium chloride | Ceftriaxone |
Sodium lactate compound | Gentamicin |
Severe pre-eclampsia and eclampsia | Oxygen |
Magnesium sulfate | Diarrhoea |
Calcium gluconate injection | Oral rehydration salts |
Hydralazine | Zinc |
Methyldopa | Malaria |
Maternal sepsis | Artemisinin-based combination therapy |
Ampicillin | Artesunate (rectal, injection) |
Gentamicin | Neonatal sepsis |
Metronidazole | Ampicillin |
Provision of safe abortion services and/or the management of incomplete abortion and miscarriage | Ceftriaxone |
Gentamicin | |
Procaine benzylpenicillin | |
Misoprostol | Vitamin A deficiency |
Mifepristone+misoprostol | Vitamin A |
Sexually transmitted infections | Palliative care and pain |
Azithromycin | Morphine |
Cefixime | Paracetamol |
Benzathine benzylpenicillin | Vaccines |
Management of preterm labour | Vaccines (national schedule) |
Nifedipine | HIV |
Dexamethasone | Standard regimen for first-line |
Betamethasone | antiretroviral treatment |
Prevention of tetanus in mother and newborn | |
Tetanus vaccine | |
Contraception | |
Oral contraceptives |
Source: Priority life-saving medicines for women and children 2012 http://apps.who.int/iris/bitstream/10665/75154/1/WHO_EMP_MAR_2012.1_eng.pdf?ua=1.